SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+7.96%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.32B
AUM Growth
+$1.32B
(+9.9%)
Cap. Flow
+$196M
Cap. Flow
% of AUM
14.83%
Top 10 Holdings %
Top 10 Hldgs %
42.53%
Holding
111
New
24
Increased
21
Reduced
23
Closed
30
Top Buys
| 1 |
NovoCure
NVCR
|
$81.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$65.8M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$46.1M |
| 4 |
Integra LifeSciences
IART
|
$28.9M |
| 5 |
AstraZeneca
AZN
|
$26.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$35.3M |
| 2 |
IDEAYA Biosciences
IDYA
|
$33.2M |
| 3 |
Revolution Medicines
RVMD
|
$22M |
| 4 |
10x Genomics
TXG
|
$21.5M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$15.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
GeneDx Holdings
WGS
$3.72B
| $307K | 0.02% |
+4,000
| New | +$307K |
|
77
Tenet Healthcare
THC
$16.3B
| $256K | 0.02% |
+2,027
| New | +$256K |
|
|
ONC
78
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $212K | 0.01% |
1,150
-81,600
| -99% | -$15.1M |
|
79
Elevance Health
ELV
$71.8B
| $203K | 0.01% |
550
-29,100
| -98% | -$10.7M |
|
80
IO Biotech
IOBT
$104M
| $177K | 0.01% |
192,670
| – | – |
|
81
Arvinas
ARVN
$568M
| – | – |
-228,800
| Closed | -$5.64M |
|
82
BioAtla
BCAB
$26.7M
| – | – |
-2,517,478
| Closed | -$4.43M |
|
|
BCYC
83
Bicycle Therapeutics
BCYC
$511M
| – | – |
-78,315
| Closed | -$1.77M |
|
84
Biodesix
BDSX
$62.6M
| – | – |
-4,038,065
| Closed | -$7.19M |
|
85
Bausch Health
BHC
$2.74B
| – | – |
-1,424,000
| Closed | -$11.6M |
|
86
CervoMed
CRVO
$83.7M
| – | – |
-126,614
| Closed | -$1.85M |
|
87
Dyne Therapeutics
DYN
$1.92B
| – | – |
-117,500
| Closed | -$4.22M |
|
88
enGene Holdings
ENGN
$236M
| – | – |
-800,000
| Closed | -$5.28M |
|
89
Enanta Pharmaceuticals
ENTA
$180M
| – | – |
-785,546
| Closed | -$8.14M |
|
|
90
IDEAYA Biosciences
IDYA
$2.15B
| – | – |
-1,049,314
| Closed | -$33.2M |
|
91
Immunovant
IMVT
$2.56B
| – | – |
-9,678
| Closed | -$276K |
|
92
OrthoPediatrics
KIDS
$536M
| – | – |
-288,945
| Closed | -$7.83M |
|
93
Kiniksa Pharmaceuticals
KNSA
$2.48B
| – | – |
-302,500
| Closed | -$7.56M |
|
94
Keros Therapeutics
KROS
$618M
| – | – |
-224,600
| Closed | -$13M |
|
95
Summit Therapeutics
SMMT
$17.6B
| – | – |
-285,000
| Closed | -$6.24M |
|
96
Treace Medical Concepts
TMCI
$464M
| – | – |
-887,941
| Closed | -$5.15M |
|
97
Tango Therapeutics
TNGX
$747M
| – | – |
-343,152
| Closed | -$2.64M |
|
|
98
10x Genomics
TXG
$1.74B
| – | – |
-951,000
| Closed | -$21.5M |
|
99
Veracyte
VCYT
$2.39B
| – | – |
-54,303
| Closed | -$1.85M |
|
100
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|